Found 259 matching trials
Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
PHASE1This study will test the safety and effectiveness of letrozole in treating ...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
PHASE3The main purpose of this study is to evaluate how effective nonsteroidal ar...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers
Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.
PHASE2The CHEOPS study aims to confirm the clinical benefit of a combination of a...
Location
Centre Hospitalier de l'Agglomération Montargoise
Evaluation of Different Doses of Letrozole in Ectopic Pregnancy
PHASE4The utilization of letrozole at a daily dose of 10 mg for medical treatment...
Location
Mohamed ALI Alabiad
Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer
PHASE2This study is a single-arm, open-label, phase II study, comparing the effic...
Location
Fuzhou general hospital
DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs
PHASE3The HER2 status in breast cancer patients may change during the course of t...
Location
University Hospital Ulm
Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure
NATo compare the abv3-integrin expression in endometrium tissue among RIF wom...
Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.
N/AThe ATLANT study is prospective, multicentre, non-interventional, observati...
Location
Russian Society of Clinical Oncology
ALPINE: Maintenance Letrozole/Abemaciclib
PHASE2The purpose of this research study is to see if the study drugs abemaciclib...
Location
Beth Israel Deaconess Medical Center
QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy
PHASE2This study will evaluate whether adding QL1706 (iparomlimab and tuvonralima...
Location
Multiple Locations